Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

U S Global Investors (GROW) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for U S Global Investors (GROW) over the last 16 years, with Q3 2025 value amounting to $24.6 million.

  • U S Global Investors' Cash & Equivalents fell 1006.0% to $24.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.6 million, marking a year-over-year decrease of 1006.0%. This contributed to the annual value of $24.6 million for FY2025, which is 1039.09% down from last year.
  • Per U S Global Investors' latest filing, its Cash & Equivalents stood at $24.6 million for Q3 2025, which was down 1006.0% from $24.6 million recorded in Q2 2025.
  • U S Global Investors' 5-year Cash & Equivalents high stood at $27.5 million for Q4 2023, and its period low was $9.5 million during Q1 2021.
  • For the 5-year period, U S Global Investors' Cash & Equivalents averaged around $23.7 million, with its median value being $24.9 million (2023).
  • As far as peak fluctuations go, U S Global Investors' Cash & Equivalents soared by 65314.53% in 2021, and later crashed by 1039.09% in 2025.
  • Over the past 5 years, U S Global Investors' Cash & Equivalents (Quarter) stood at $23.2 million in 2021, then rose by 1.02% to $23.4 million in 2022, then increased by 17.3% to $27.5 million in 2023, then decreased by 5.19% to $26.0 million in 2024, then decreased by 5.58% to $24.6 million in 2025.
  • Its Cash & Equivalents was $24.6 million in Q3 2025, compared to $24.6 million in Q2 2025 and $26.3 million in Q1 2025.